We found that XBP1 was significantly correlated with key immunity-killing molecules, including FASL (Figure 4A), PRF1 (Figure 4B), IFNG (Figure 4C), GZMB (Figure 4D), TNFa (Figure 4E), and CD40L (Figure 4F) in ovarian cancer. Here, PRF1 is linked to ovarian carcinoma.